The Foot & Ankle Consolidation Trend Continues
- kshepherd72
- May 19, 2022
- 1 min read
On May 4, CONMED Corporation (NYSE: CNMD) announced a definitive agreement to acquire privately-held In2Bones Global, Inc. for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period.
In2Bone, led by foot and ankle veteran Alan Taylor, had 2021 revenue of $36.8 million with sustained double-digit growth. While CONMED is a large company, including 3,500 employees, it has a small footprint in foot and ankle, making this a partnership an upside on both sides.
Recent Posts
See AllName changes, like the recent reversion of Alaska’s Denali back to its former name, Mount McKinley , are seen as a current form of power...
by Vince Vacketta, DPM Joint line height has been established as an influential parameter in TAA, with previous research showing that an...
When treating ankle fractures, the conventional wisdom typically involves a long, six-week period of non-weight bearing (NWB). But, what...
Comentarios